Arkolith/Insider Trading/MIST/Form 4

Muller Lorenz

Chief Commercial OfficerMilestone Pharmaceuticals Inc. (MIST) · full profile →Form 4 · filed Jan 29, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 27, 2025Grant(A)121K—$0121K
Jan 27, 2025Grant(A)80K—$080K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-002268) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML